Amneal Pharmaceuticals, Inc. (AMRX) › Cash & EquivalentsAmneal Pharmaceuticals, Inc. (AMRX) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2016-12-31: $27.37M2017-10-04: $02017-12-31: $74.17M2018-12-31: $213.39M2019-12-31: $151.20M2020-12-31: $341.38M2021-12-31: $247.79M2022-12-31: $25.98M2023-12-31: $91.54M2024-12-31: $110.55M2025-12-31: $282.03M$282.03M2016-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$282.03M+155.1%2026-02-27Balance as of period end2024-12-31$110.55M+20.8%2026-02-27Balance as of period end2023-12-31$91.54M+252.4%2026-02-27Balance as of period end2022-12-31$25.98M-89.5%2025-02-28Balance as of period end2021-12-31$247.79M-27.4%2024-03-14Balance as of period end2020-12-31$341.38M+125.8%2023-03-03Balance as of period end2019-12-31$151.20M-29.1%2022-03-01Balance as of period end2018-12-31$213.39M+187.7%2021-03-01Balance as of period end2017-12-31$74.17M—2020-03-02Balance as of period end2017-10-04$0—2018-03-09Balance as of period end2016-12-31$27.37M—2019-03-01Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)